Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonah Bergman

Optometrist New York, NY Doctor of Optometry

NPI 1356439624 CMS profile 743785

205 E 64Th St Ste 101, New York, NY 10065

Open in the dashboard

General payments

$11,566

271 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonah Bergman of New York, NY is reported in the CMS Open Payments database as having received $11,566 across 271 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,463 46
2024 General $1,936 60
2023 General $1,883 55
2022 General $1,456 39
2021 General $997 27
2020 General $701 22
2019 General $3,128 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonah Bergman
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Jonah Bergman were reported at $1,463. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Jonah Bergman Optometrist median Middle half National median
2019 $3,128 $159 $67–$371 $163
2020 $701 $72 $29–$165 $114
2021 $997 $125 $46–$292 $132
2022 $1,456 $162 $66–$374 $149
2023 $1,883 $177 $72–$406 $160
2024 $1,936 $188 $77–$427 $164
2025 $1,463 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb, a division of Bausch Health US, LLC $2,796 17 payments
  2. Sun Pharmaceutical Industries Inc. $1,857 72 payments
  3. Bausch & Lomb Americas Inc. $1,014 20 payments
  4. Johnson & Johnson Vision Care, Inc. $995 19 payments
  5. Oyster Point Pharma, Inc. $979 34 payments
  6. Alcon Vision LLC $626 24 payments
  7. Allergan Inc. $534 6 payments
  8. AbbVie, Inc. $528 18 payments
  9. Johnson & Johnson Surgical Vision, Inc. $406 7 payments
  10. Amgen Inc. $376 3 payments
  11. Other $1,456 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,616 269 payments
  2. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,950 2 payments
Products named General payments · program years 2019–2025
  1. VYZULTA $2,738 16 payments
  2. Cequa $1,807 69 payments
  3. Acuvue $822 13 payments
  4. TYRVAYA Dry Eye $504 18 payments
  5. enVista MX60 IOL $406 3 payments
  6. LOTEMAX SM $380 8 payments
  7. MIEBO $379 9 payments
  8. TEPEZZA $376 3 payments
  9. TYRVAYA Dry eyes $358 12 payments
  10. XIIDRA $308 18 payments
  11. Other $4,826 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

271 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record